title: Evaluation of the high-pressure extrusion technique as a method for sizing plasmid DNA-containing cationic liposomes.
abstract: A promising strategy to improve the immunogenic potential of DNA vaccines is the formulation of plasmid DNA (pDNA) with cationic liposomes. In this respect, particle size may be of crucial importance. This study aimed at the evaluation of high-pressure extrusion as a method for sizing cationic liposomes after entrapment of pDNA. This is a well-known sizing method for liposomes, but so far, it has not been applied for liposomes that are already loaded with pDNA. Liposomes composed of egg PC, DOTAP, and DOPE with entrapped pDNA were prepared by the dehydration-rehydration method and subjected to various extrusion cycles, comparing different membrane pore sizes and extrusion frequencies. At optimized extrusion conditions, liposome diameter (Zave) and polydispersity index (PDI) were reduced from 560 nm and 0.56-150 nm and 0.14 respectively, and 35% of the pDNA was retained. Importantly, gel electrophoresis and transfection experiments with pDNA extracted from these extruded liposomes demonstrated the preservation of the structural and functional integrity of the pDNA. The reduction in size resulted in enhanced transfection of HeLa cells, as detected by functional expression of the fluorescent protein, eGFP. In addition, these liposomes were able to stimulate Toll-like receptor 9, indicating efficient endosomal uptake and release of the included pDNA. In conclusion, high-pressure extrusion is a suitable technique to size cationic liposomes with entrapped pDNA and allows preparation of well-defined nanosized pDNA-liposomes, with preserved pDNA integrity. Their improved transfection efficiency and ability to activate an important pattern-recognition receptor are favorable properties for DNA vaccine delivery vehicles.
authors.affiliation: Division of Drug Delivery Technology, Leiden/Amsterdam Center for Drug Research (LACDR), Faculty of Science, Leiden University, Leiden, The Netherlands.
authors.forename: Myrra G
authors.initials: MG
authors.lastname: Carstens
authors.forename: Koen
authors.initials: K
authors.lastname: van der Maaden
authors.forename: Daniel
authors.initials: D
authors.lastname: van der Velden
authors.forename: Tom H M
authors.initials: TH
authors.lastname: Ottenhoff
authors.forename: Cornelis J
authors.initials: CJ
authors.lastname: Melief
authors.forename: Ferry
authors.initials: F
authors.lastname: Ossendorp
authors.forename: Joke A
authors.initials: JA
authors.lastname: Bouwstra
authors.forename: Wim
authors.initials: W
authors.lastname: Jiskoot
mesh_terms: D002412:Cations / Q000737:chemistry*; D002470:Cell Survival; D020285:Cryoelectron Microscopy; D004247:DNA / Q000737:chemistry*; D004337:Drug Carriers / Q000737:chemistry; D018014:Gene Transfer Techniques; D057809:HEK293 Cells; D006367:HeLa Cells; D006801:Humans; D008081:Liposomes / Q000138:chemical synthesis* / Q000737:chemistry* / Q000648:ultrastructure; D053758:Nanoparticles / Q000737:chemistry; D010316:Particle Size; D010957:Plasmids / Q000235:genetics*; D011312:Pressure; D051217:Toll-Like Receptor 9 / Q000378:metabolism
chemical_list: D002412:Cations; D004337:Drug Carriers; D008081:Liposomes; D051217:Toll-Like Receptor 9; D004247:DNA